NASDAQ
enVVeno Medical Corporation (NVNO) has a free cash flow growth of 5.95% as of Friday, May 29, 2026. This represents a 26.30% decrease compared to its 12-month average of 8.08%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.